Document Detail

Non-random cell killing in cryopreservation: implications for performance of the battery of leukocyte tests (BLT), I. Toxic and immunotoxic effects.
MedLine Citation:
PMID:  1996128     Owner:  NLM     Status:  MEDLINE    
To eliminate between-tests error in longitudinal human studies, for specimen sharing, convenient scheduling, etc., it is necessary for us to freeze leukocytes as well as non-transformed, continuous T lymphocyte (CTL) lines. Two commonly used cryopreservation methods were compared in terms of efficacy. Isolated peripheral blood mononuclear cells and CTLs were each aliquoted into three sets of vials. Two sets each were frozen in a 1:1 mixture of 15% DMSO in Mixed Medium (MM) and 20% FBS in MM using a commonly employed styrofoam freezer insert method for liquid nitrogen refrigerators and a programmed freezer (temperature falls at an optimal rate), respectively. The remaining set was held in MM with 20% FBS at 20 degrees C during the 2-h freezing process. The cells were thawed and/or washed and assayed for viability and T helper (Th)/T suppressor (Ts) ratio. It is clear that inadequate freezing (via the styrofoam method) non-randomly damages cells of T cell subpopulations, Th being more sensitive than Ts. Further, it is shown that inadequate cryopreservation can confound results from a number of assessment methods owing to morphological and functional damages. The battery of leukocyte tests (BLT) under development in this laboratory, is designed to detect toxic, immunotoxic and genotoxic effects of in vivo mutagen exposure on human blood. It is concluded that minimization of non-random cell losses (as quantitated on the basis of morphology) and preservation of related regulatory cell function is essential if one would assess the in vivo and in vitro states of heterogeneous cells. Further, it is suggested that freezing methods should be used only after verification that selective damage to subpopulations is not occurring among cells that otherwise might wrongly be assumed to be intact.
G H Strauss
Related Documents :
20368948 - Influence of preserved brewing yeast strains on fermentation behavior and flocculation ...
19845078 - Cryopreserving and deglycerolizing sickle cell trait red blood cell components using an...
16527318 - Accumulation of theanderose in association with development of freezing tolerance in th...
12802048 - Detailed investigation of factors influencing amplification efficiency and allele drop-...
8097968 - Non-glucocorticoid steroid analogues (21-aminosteroids) sensitize multidrug resistant c...
15374998 - Functional interaction between tumor suppressor menin and activator of s-phase kinase.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Mutation research     Volume:  252     ISSN:  0027-5107     ISO Abbreviation:  Mutat. Res.     Publication Date:  1991 Feb 
Date Detail:
Created Date:  1991-03-25     Completed Date:  1991-03-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0400763     Medline TA:  Mutat Res     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  1-15     Citation Subset:  IM    
U.S. Environmental Protection Agency, Health Effects Research Laboratory, Genetic Toxicology Division, Research Triangle Park, NC 27711.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Component Removal
Cell Line
Cell Survival / drug effects
Cryopreservation / methods*
Dimethyl Sulfoxide / toxicity
Fluoresceins / toxicity
Interleukin-2 / biosynthesis
Leukocyte Count
Leukocytes, Mononuclear / drug effects*
Lymphocyte Activation / drug effects
Reg. No./Substance:
0/Fluoresceins; 0/Interleukin-2; 3301-79-9/6-carboxyfluorescein; 67-68-5/Dimethyl Sulfoxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Recommended protocols based on a survey of current practice in genotoxicity testing laboratories: st...
Next Document:  Inhalation exposure in Drosophila mutagenesis assays: experiments with aliphatic halogenated hydroca...